Mattioli S - Search Results

1

Construction of a superantigen through a structural modification of an inactive protein.

Imberti L, Sottini A, Quiros E, Mattioli S, Prati E, Albertini A, Primi D. Imberti L, et al. Among authors: mattioli s. Ann N Y Acad Sci. 1995 Jul 7;756:117-9. doi: 10.1111/j.1749-6632.1995.tb44495.x. Ann N Y Acad Sci. 1995. PMID: 7645815 No abstract available.

2

Insertion of a short human immunodeficiency virus (HIV)-2 gp36 sequence into an HIV-1 p24 recombinant protein results in a polypeptide with potent and TCRBV-restricted T cell triggering activity.

Imberti L, Sottini A, Quiròs Roldan E, Albertini A, Mattioli S, Prati E, Primi D. Imberti L, et al. Among authors: mattioli s. Eur J Immunol. 1995 Jan;25(1):218-25. doi: 10.1002/eji.1830250136. Eur J Immunol. 1995. PMID: 7843234

3

Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.

Mattioli S, Imberti L, Stellini R, Primi D. Mattioli S, et al. J Virol. 1995 Sep;69(9):5294-9. doi: 10.1128/JVI.69.9.5294-5299.1995. J Virol. 1995. PMID: 7543581 Free PMC article.

4

Superantigen-reactive human T cells express a biased repertoire of T-cell receptor V beta joining regions.

Quiròs Roldan E, Sottini A, Imberti L, Mattioli S, Albertini A, Primi D. Quiròs Roldan E, et al. Among authors: mattioli s. Res Immunol. 1994 Sep;145(7):517-31. doi: 10.1016/s0923-2494(94)80070-7. Res Immunol. 1994. PMID: 7754198

5

Potential circulating markers for the management of kidney cancer (Review).

Botti C, Seregni E, Mattioli S, Massaron S, Bonanate A, Cantarella D, Bombardieri E. Botti C, et al. Among authors: mattioli s. Int J Oncol. 1997 Jan;10(1):147-57. doi: 10.3892/ijo.10.1.147. Int J Oncol. 1997. PMID: 21533358

6

Lithotripsy with a Q-switched alexandrite laser system. Preliminary in vivo and in vitro results.

Mattioli S, Cremona M, Benaim G, Ferrario A. Mattioli S, et al. Eur Urol. 1991;19(3):233-5. doi: 10.1159/000473627. Eur Urol. 1991. PMID: 1677335

7

Bladder cancer monitoring using two novel urinary markers.

Botti C, Seregni E, Mattioli S, Martinetti A, Ferrari L, Bombardieri E. Botti C, et al. Among authors: mattioli s. Int J Biol Markers. 1997 Oct-Dec;12(4):174-80. doi: 10.1177/172460089701200407. Int J Biol Markers. 1997. PMID: 9582608 Review.

8

BTA-TRAK combined with urinary cytology is a reliable urinary indicator of recurrent transitional cell carcinoma (TCC) of the bladder.

Mattioli S, Seregni E, Caperna L, Botti C, Savelli G, Bombardieri E. Mattioli S, et al. Int J Biol Markers. 2000 Jul-Sep;15(3):219-25. Int J Biol Markers. 2000. PMID: 11012097

9

[Transurethral and percutaneous treatment of ureteropyelocaliceal tumors with electrocoagulation, resection and lasers].

Franch L, Milani C, Rippa A, Galbiati G, Manganini V, Cavenaghi R, Mattioli S, Cremona M. Franch L, et al. Among authors: mattioli s. Arch Esp Urol. 1988 Jun;41(5):373-6. Arch Esp Urol. 1988. PMID: 3190274 Spanish. No abstract available.

10

[Treatment of benign prostatic hyperplasia with the Revolix laser].

Mattioli S, Muñoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H. Mattioli S, et al. Arch Esp Urol. 2008 Nov;61(9):1037-43. Arch Esp Urol. 2008. PMID: 19140585 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters